S'abonner

Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope?—Global Registry for Emerging Fungal Infections - 31/10/20

Doi : 10.1016/j.jinf.2020.08.015 
Jon Salmanton-García a , Philipp Koehler a, b, Anupma Kindo c, Iker Falces-Romero d, Julio García-Rodríguez d, Zdeněk Ráčil e, f, g, Sharon C.-A. Chen h, i, Nikolai Klimko j, Guillaume Desoubeaux k, l, George R. Thompson m, n, Miguel-Ángel Benítez-Peñuela o, José-Yesid Rodríguez o, Donald C. Sheppard p, Martin Hoenigl q, r, s, Yohann Le Govic t, Hamid Badali u, John W. Baddley v, w, x, Jagdish Chander y, Paul R. Ingram z, aa, Diana L. Pakstis bb, Sibylle C. Mellinghoff a, Serkan Atıcı cc, Simone Cesaro dd, Arunaloke Chakrabarti ee, Damien Dupont ff, gg, Gloria M. González hh, Lóránt Hatvani ii, jj, Raoul Herbrecht kk, Galina Klyasova ll, Cornelia Lass-Flörl mm, Mihai Mareș nn, Kathleen Mullane oo, Donald C. Vinh pp, Hilmar Wisplinghoff qq, rr, ss, Michaela Lackner mm, Oliver A. Cornely a, tt, uu, vv, Danila Seidel a,
The FungiScope

ECMM/ISHAM working group1

  On behalf of The FungiScope ECMM/ISHAM Working Group.
Barbara D. Alexander, María Almagro-Molto, Eduardo Álvarez-Duarte, Martha Avilés-Robles, Aleksandra Barać, Vanda Chrenková, Patricia Cornejo-Juárez, Nicole Desbois-Nogard, Mario Fernández-Ruiz, Luis Figueira, Jesús García-Martínez, Sandra Gräber, Barbara Graf, Georg Haerter, Shariq Haider, Pamela Hartman, Melina Heinemann, Aamer Ikram, Frédéric Janvier, Jeffrey D. Jenks, Carol Kauffman, Robert Krause, Me-Linh Luong, Shruti Malik, Vincent Marconi, Rodrigo Martino, Sanjay R. Mehta, Lisa Meintker, Andrea Mocná, Michele I. Morris, Alessandro C. Pasqualotto, Atul Patel, Olaf Penack, Nicolas Pichon, Mathias W. Pletz, Carlos Seas, Uluhan Sili, Monica Slavin, Kenji Uno, Jose A. Vazquez, Thomas Weber, Barbora Weinbergerova, Deniz Yilmaz-Karapinar, Seda Yilmaz-Semerci, Jin Yu

a University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Excellence Center for Medical Mycology (ECMM), Herderstrasse 52-54, 50931 Cologne, Germany 
b University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany 
c Department of Microbiology, Sri Ramachandra Medical College and Research Institute, SRIHER, Chennai, India 
d Clinical Microbiology and Parasitology Department, University Hospital La Paz, Madrid, Spain 
e Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic 
f University Hospital Brno, Brno, Czech Republic 
g Institute of Hematology and Blood Transfusion, Prague, Czech Republic 
h Centre for Diseases and Microbiology Laboratory Services, ICPMR, New South Wales Health Pathology, Westmead Hospital, Sydney, NSW, Australia 
i The University of Sydney, Westmead, Sydney, NSW, Australia 
j Mechnikov North-Western State Medical University, St. Petersburg, Russian Federation 
k Parasitologie - Mycologie - Médecine Tropicale, CHU de Tours, France 
l Centre d'Etude des Pathologies Respiratoires - Unité Inserm U1100, Université de Tours, Tours, France 
m Department of Internal Medicine Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA, United States 
n Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, CA, United States 
o Center of Microbiological Research of Cesar (CIMCE), Rosario Pumarejo de López Hospital, Laura Daniela Clinic, Médicos Clinic LTDA, Valledupar, Colombia 
p Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada 
q Clinical and Translational Fungal—Working Group, University of California San Diego, La Jolla, CA, United States 
r Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA, United States 
s ECMM Excellence Center for Clinical Mycology, Section of Infectious Diseases and Tropical Medicine and Division of Pulmonology, Medical University of Graz, Graz, Austria 
t Parasitology-Mycology Unit, University Hospital Center, Fort-de-France, Martinique, French West Indies 
u Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran 
v Department of Internal Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL, United States 
w Medical Service, Birmingham VA Medical Center, AL, United States 
x Institute for Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States 
y Department of Microbiology, Government Medical College and Hospital, Chandigarh, India 
z Department of Infectious Diseases, Royal Perth Hospital, Perth, WA, Australia 
aa School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia 
bb Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Palestine, State of, United States 
cc Department of Pediatrics, Division of Pediatric Infectious Disease, Okan University School of Medicine, Istanbul, Turkey 
dd Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Italy 
ee Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Research, Chandigarh, India 
ff Institut des Agents Infectieux, Parasitologie Mycologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France 
gg Integrative Physiology of the Brain Arousal Systems, Centre de Recherche en Neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Faculté de Médecine, Université Claude Bernard Lyon 1, Lyon, France 
hh Department of Microbiology, School of Medicine, Universidad Autonóma de Nuevo León, Nuevo León, Mexico 
ii MTA-SZTE “Lendület” Mycobiome Research Group, Szeged, Hungary 
jj Department of Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary 
kk Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg and Université de Strasbourg, Inserm, UMR-S1113/IRFAC, Strasbourg, France 
ll epartment of Clinical Microbiology, Mycology and Antibiotic Therapy, National Research Center for Hematology, Moscow, Russia 
mm Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria 
nn Laboratory of Antimicrobial Chemotherapy, Ion Ionescu de la Brad University, Iași, Romania 
oo Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States 
pp Research Institute - McGill University Health Centre, Infectious Diseases and Immunity in Global Health Program, Montreal, QC, Canada 
qq Wisplinghoff Laboratories, Cologne, Germany 
rr Institute for Medical Microbiology, University of Cologne, Cologne, Germany 
ss Institute for Virology and Microbiology, Witten/Herdecke University, Witten, Germany 
tt German Centre for Infection Research (DZIF), partner site Bonn - Cologne, Cologne, Germany 
uu Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany 
vv Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany 

Corresponding author.

Highlights

To date, 186 cases of extremely rare IFI have been documented in FungiScope.
Dematiaceae, Hypocreales, Mucorales, and Saccharomycetales caused most of the IFI.
Favorable response rate was highest in Eurotiales (82.4%) and in Agaricales (80.0%).
Overall mortality rate ranged from 11.8% in Eurotiales to 50.0% in Mucorales.
International consortiums are core to evaluate the epidemiology of extremely rare IFI.

Le texte complet de cet article est disponible en PDF.

Abstract

Objectives

Emerging invasive fungal infections (IFI) have become a notable challenge. Apart from the more frequently described fusariosis, lomentosporiosis, mucormycosis, scedosporiosis, and certain dematiaceae or yeasts, little is known about extremely rare IFI.

Methods

Extremely rare IFI collected in the FungiScope registry were grouped as Dematiaceae, Hypocreales, Saccharomycetales, Eurotiales, Dermatomycetes, Agaricales, and Mucorales.

Results

Between 2003 and June 2019, 186 extremely rare IFI were documented in FungiScope. Dematiaceae (35.5%), Hypocreales (23.1%), Mucorales (11.8%), and Saccharomycetales (11.3%) caused most IFI. Most patients had an underlying malignancy (38.7%) with acute leukemia accounting for 50% of cancers. Dissemination was observed in 26.9% of the patients. Complete or partial clinical response rate was 68.3%, being highest in Eurotiales (82.4%) and in Agaricales (80.0%). Overall mortality rate was 29.3%, ranging from 11.8% in Eurotiales to 50.0% in Mucorales.

Conclusions

Physicians are confronted with a complex variety of fungal pathogens, for which treatment recommendations are lacking and successful outcome might be incidental. Through an international consortium of physicians and scientists, these cases of extremely rare IFI can be collected to further investigate their epidemiology and eventually identify effective treatment regimens.

Le texte complet de cet article est disponible en PDF.

Keywords : Rare, Invasive fungal infections, Registry, Mold, Yeast


Plan


© 2020  The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 81 - N° 5

P. 802-815 - novembre 2020 Retour au numéro
Article précédent Article précédent
  • Excess mortality due to COVID-19 in Germany
  • Andreas Stang, Fabian Standl, Bernd Kowall, Bastian Brune, Juliane Böttcher, Marcus Brinkmann, Ulf Dittmer, Karl-Heinz Jöckel
| Article suivant Article suivant
  • Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration
  • Ji Yun Noh, Jin Gu Yoon, Hye Seong, Won Suk Choi, Jang Wook Sohn, Hee Jin Cheong, Woo Joo Kim, Joon Young Song

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.